Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration
Eversense 365 now works with iLet, combining a year of accurate glucose monitoring with fully adaptive, automated insulin delivery to...
Eversense 365 now works with iLet, combining a year of accurate glucose monitoring with fully adaptive, automated insulin delivery to...
Agreement to acquire Aytu BioPharma for all-cash consideration of $2.70 per Aytu share.Proposed acquisition brings an established ADHD portfolio and...
NASHVILLE, Tenn., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) (“iMDx,” “we,” “us,” “our,” or the...
PETACH TIKVA, Israel, Nov. 16, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), a leader in...
– Reported positive preliminary topline data from global Phase 2 Seabreeze STAT studies evaluating rademikibart as an adjunct treatment for...
On Track to Complete Enrollment of Phase 3 ELAINE-3 Clinical Trial of Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast...
OneTest™ Revenue Increased 4.1% to $1.36 Million for First Nine Months of 2026, with Gross Margin Expanding to 32.8% Vermont...
Initiated Himalayas-1 global Phase 3 trial in patients with mCRPC previously treated with abiraterone, supported by a clinical trial collaboration...
Revenue of $56.8 million, compared to $47.0 million in the second quarter of 2026 and $26.2 million in the third...
Completed restructuring of royalty financing agreement, reducing the maximum aggregate payment obligation by $60 million, with only $15 million in...
MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime...
24-Week interim data shows neflamapimod delivered an exposure-dependent reduction in neurofilament light chain, a key biomarker of neuronal damage Full...
BASEL, Switzerland, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Windward Bio Group AG ("Windward") (Nasdaq: WWB), a clinical-stage biotechnology company developing...
DARE to PLAY™ Sildenafil Cream prescription dispensing activities underway this month, with prescriptions written across 48 states and Washington, D.C....
Q3 Revenue of $10.4 millionQ3 Thyroid volume year-over-year increase of 7%Q3 Thyroid revenue year-over-year increase of 18%Trailing twelve-month thyroid revenue...
CARLSBAD, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company...
To support its efforts around health preparedness, Emergent will use Asimov’s CHO Edge System to help develop novel medical countermeasuresBOSTON...
LEXINGTON, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical...
– Strategic research collaboration leverages Stipple Bio's innovative Pointillist Platform to identify tumor-specific cell surface epitope binders and Lilly’s proprietary...